AQ2-33867-47306
3 vaccinations
4 coded responses
30 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 603 / IL
- Registered
- 2020-12-24
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-19
Dose 1 — Pfizer-BioNTech
-
2020-12-24
Registered in v-safe
- 2020-12-24
- 2020-12-28
- 2021-01-02
-
2021-01-09
Dose 2 — Pfizer-BioNTech
-
2021-01-09
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Chills, Headache, Fatigue or tiredness, Abdominal painAdult check-in
-
2021-01-10
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-10
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-11
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-12
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-01-13
- 2021-01-15
- 2021-01-16
- 2021-01-30
- 2021-02-06
-
2021-02-20
Survey response — day 42, dose 2MedDRA: Fatigue, Oropharyngeal pain, Rhinorrhoea — Feeling: FairFree text: Runny nose, sore throat, fatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-12
-
2021-09-29
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2021-09-29
-
2021-09-30
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-10-01
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fatigue or tiredness, Abdominal painAdult check-in
-
2021-10-02
Survey response — days 1–6 daily, dose 3MedDRA: Oral herpes — Feeling: Good · Site: PainFree text: Cold soreMedDRA releases: 2024-11 · check-in free text available
- 2021-10-03
- 2021-10-04
- 2021-10-05
- 2021-10-06
-
2021-10-15
Survey response — day 14, dose 3MedDRA: Cluster headache, Cough, Oropharyngeal pain, Rhinorrhoea — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Rhinorrhea, headaches, cough, sore throatMedDRA releases: 2024-11 · check-in free text available
- 2021-10-22
- 2021-10-29
- 2021-11-03
- 2021-11-11
- 2021-12-29
-
2022-03-30
Survey response — 6 months, dose 3MedDRA: COVID-19, Fatigue, Headache, Nausea, Pregnancy — Feeling: Good · Be unable to work or attend schoolFree text: Fatigue, headaches, Covid, nausea, pregnancyMedDRA releases: 2024-11 · check-in free text available
- 2022-09-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-19 | Pfizer-BioNTech | |
| 2 | 2021-01-09 | Pfizer-BioNTech | |
| 3 | 2021-09-29 | Pfizer-BioNTech | Flu |
Call center
1 call center case
1 priority 2/3 (triaged and no follow up)
Free text
Release 4 — day 42, dose 2
Symptoms: Runny nose, sore throat, fatigue
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Cold sore
Release 10 — day 14, dose 3
Symptoms: Rhinorrhea, headaches, cough, sore throat
Release 11 — 6 months, dose 3
Symptoms: Fatigue, headaches, Covid, nausea, pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cluster headache | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SRO | Oral herpes | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release